Matches in Nanopublications for { ?s ?p "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP561777.RAWIHSBR_gV4mWdpSRb_fKKJxzpYOOcpyuhiXfQWbvoMM130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561777.RAWIHSBR_gV4mWdpSRb_fKKJxzpYOOcpyuhiXfQWbvoMM130_provenance.
- NP293536.RADdDBbygCLWmdKK4tLsCbRYNDyK0Kdaosc2SAR724Q3g130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293536.RADdDBbygCLWmdKK4tLsCbRYNDyK0Kdaosc2SAR724Q3g130_provenance.
- NP594070.RA1WKr3iTt5J2K29mk2Qa205_N66ue_6DlTHCBvu7EhKA130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594070.RA1WKr3iTt5J2K29mk2Qa205_N66ue_6DlTHCBvu7EhKA130_provenance.
- NP354030.RAQkjRg_DRyDoghMvtKm_ulCXblqDrtiHCD3Y5_RzxOZc130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354030.RAQkjRg_DRyDoghMvtKm_ulCXblqDrtiHCD3Y5_RzxOZc130_provenance.
- NP328742.RArpOc-GNSRvxWD7R77Kq5e-spYwxEWxKRKn5fP9GuCHo130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328742.RArpOc-GNSRvxWD7R77Kq5e-spYwxEWxKRKn5fP9GuCHo130_provenance.
- NP418830.RAdbliiMGx_PFmZhRLR86rQTVJES2YapdJD4X4XsHafwo130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418830.RAdbliiMGx_PFmZhRLR86rQTVJES2YapdJD4X4XsHafwo130_provenance.
- NP328672.RA0-HscwfFmEcXO1tqs1rDg0t8iBndSH92eaHlMWpvL04130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328672.RA0-HscwfFmEcXO1tqs1rDg0t8iBndSH92eaHlMWpvL04130_provenance.
- NP418827.RA8M6KC2XZLHM0ZE1SZhONDdm6okqKTBFFsdU_obWlYBo130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418827.RA8M6KC2XZLHM0ZE1SZhONDdm6okqKTBFFsdU_obWlYBo130_provenance.
- NP418829.RA6GdrLOLmUi4AhgkZTPkSHm2Qm0Rngc1BVfUeZLR011I130_assertion description "[To determine whether the human (h) NQO1 (NAD(P)H: quinone oxidoreductase 1) gene contains DNA sequences that directly mediate its high and low expression in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC), respectively, a series of deletion constructs spanning up to -4kb of the 5(') flanking region of hNQO1 was used in transient transfection assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418829.RA6GdrLOLmUi4AhgkZTPkSHm2Qm0Rngc1BVfUeZLR011I130_provenance.